Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinical impact of the first‐trimester nuchal translucency between the 95th–99th percentiles

1 Jun 2023

Abstract excerpt

OBJECTIVES: To evaluate the clinical significance of nuchal translucency (NT) between the 95th-99th percentile in terms of typical and atypical chromosomal abnormalities (ACAs), associated fetal congenital defects and postnatal outcome. METHODS: A retrospective cohort study of fetuses with NT between the 95th-99th percentile. Data regarding the rate of associated fetal defects, genetic abnormalities and postnatal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Congenital Diaphragmatic Hernia Studies
Share to Fetal and Pediatric Neurological Disorders
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37264704
DOI: 10.1002/pd.6390

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinical impact of the first‐trimester nuchal translucency between the 95th–99th percentilesPMID 37264704Read ↗

Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?Semantic proximity Read ↗

Elevated nuchal translucency, is it time to discuss the cut off?. A retrospective studySemantic proximity Read ↗

Abnormal Nuchal Translucency and Outcomes of Singleton Pregnancies (Antop) Study: An 8 -year Retrospective Cohort AnalysisSemantic proximity Read ↗

Outcomes associated with fetal nuchal translucency between 3.0 and 3.4 mm in the first trimesterSemantic proximity Read ↗

Increased nuchal translucency thickness and risk of neurodevelopmental disordersSemantic proximity Read ↗

Associations between genomic aberrations, increased nuchal translucency, and pregnancy outcomes: a comprehensive analysis of 2,272 singleton pregnancies in women under 35Semantic proximity Read ↗

Nuchal translucency of 3.0‐3.4 mm an indication for NIPT or microarray? Cohort analysis and literature reviewSemantic proximity Read ↗

Molecular genetic and pregnancy outcomes of fetuses with increased Nuchal Translucency.Semantic proximity Read ↗

Diagnostic Value of Karyotyping, CMA/CNV-Seq, and WES in Fetuses with Thickened Nuchal Translucency: Perinatal and Two-Year Follow-Up OutcomesSemantic proximity Read ↗

Cut‐off value of nuchal translucency as indication for chromosomal microarray analysisSemantic proximity Read ↗

Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort studySemantic proximity Read ↗

Application of chromosomal microarray in fetuses with increased nuchal translucencySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.